STERIS PUBLIC LIMITED COMPANY
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Miscellaneous Personal Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about STERIS PUBLIC LIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2023-11-08 (massdevice.com)
Stimvia completes enrollment in study of neurostim for Parkinson's
Stimvia announced today that it completed enrollment in a study of neuromodulation for treating Parkinson's disease and essential tremor.
Read more
2023-11-07 (massdevice.com)
Abbott launches dual-chamber pacemaker with first U.S. implants
The first U.S. commercial cases have been completed with the Abbott Aveir dual-chamber leadless pacemaker technology.
Read more
2023-09-27 (yahoo.com)
Here's Why Investors Should Retain STERIS (STE) Stock for Now
STERIS' (STE) healthcare segment benefits from procedure recovery, boosting investors' optimism.
Read more
2023-05-02 (massdevice.com)
Stryker boosts guidance — but perhaps not enough — after Street-beating Q1
Stryker handily beat Wall Street expectations during its first quarter, though its guidance range increase may have disappointed investors.
Read more
2021-12-03 (pharmaceutical-technology.com)
The end of the inversion: will pharma leave Ireland after tax rises?
Ireland recently agreed to a 15% minimum tax rate, which could have implications for the pharmaceutical companies based there.
Read more
2021-04-28 (cleanroomtechnology.com)
Case Study: Nephron pharmaceuticals compounding facility integrates VHP biodecontamination
The growing manufacturer of generic respiratory medications and a contract manufacturer of blow-fill-seal products has chosen STERIS to integrate a VHP biodecontamination system
Read more
2020-06-19 (netimesmagazine.co.uk)
Merit awarded £6 million contract to build decontamination centre for STERIS
Offsite construction specialist, Merit, has been awarded a £6 million contract by STERIS to design and build a new Decontamination Super Centre in Chessington. This will be the fifth decontamination facility the Cramlington-based company has delivered for STERIS since 2010.
Read more
2020-06-18 (theconstructionindex.co.uk)
Merit wins fifth decontamination centre
Offsite construction specialist Merit has been awarded a £6m contract by US medical company Steris to design and build a decontamination centre in Chessington, Surrey.
Read more
2020-02-07 (offalyexpress.ie)
Major multinaitonal unveils expansion at Tullamore facility
STERIS Laboratories has unveiled its brand new state-of-the-art laboratory built last year in Tullamore. Members of Offaly County Council management and the IDA were in attendance at the official opening of the new lab in the IDA Business & Technology Park at Sragh Industrial Estate on Thursday,...
Read more